Wiemken to assist on TB biomarker study
Will be part of U of L's first grant from the Bill & Melinda Gates Foundation.
The University of Louisville announced it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.
The U of L project was awarded $576,800 over two years for an interdisciplinary study headed by James E. Graham, Ph.D., associate professor of microbiology and immunology with Xiao-an “Sean” Fu, Ph.D., assistant professor of chemical engineering in the Speed School of Engineering; Richard M. Higashi, Ph.D., professor of chemistry, and Michael H. Nantz, Ph.D., professor of chemistry, in the College of Arts and Sciences; and Timothy L. Wiemken, Ph.D., instructor in Division of Infectious Diseases of the Department of Medicine in the School of Medicine.
